Review Article

Efficacy and safety of Saccharomyces boulardii in the treatment of acute gastroenteritis in the paediatric population: a systematic review

Published in: South African Journal of Clinical Nutrition
Volume 32 , issue 3 , 2019 , pages: 58–69

DOI: 10.1080/16070658.2018.1449378

Author(s): Morgambal Padayachee Division of Human Nutrition, Faculty of Medicine and Health Sciences, South Africa , Janicke Visser Division of Human Nutrition, Faculty of Medicine and Health Sciences, South Africa , Estelle Viljoen Department of Human Nutrition and Dietetics, School of Health Care Sciences, South Africa , Alfred Musekiwa Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, South Africa , Renée Blaauw Division of Human Nutrition, Faculty of Medicine and Health Sciences, South Africa

Keywords: gastroenteritis , paediatric , randomised controlled trial , Saccharomyces boulardii

Download full text Get new issue alerts

Abstract

Context: Gastroenteritis (GE) remains the second major cause of death in the most vulnerable of the world’s populations. Potential treatments include the use of probiotics, with the yeast Saccharomyces boulardii being one such option.

« Acceptability of a moringa-added complementary soft porridge to caregivers in Hammanskraal, Gauteng province and Lebowakgomo, Limpopo province, South Africa

Infant and Young Child Feeding Policy: do primary health care nurses adhere to the HIV breastfeeding recommendations in Limpopo province? »